| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.55 | 3.56▼ | 3.56▼ | 3.47▲ | 5.00▼ |
| MA10 | 3.56▼ | 3.54▲ | 3.51▲ | 4.13▼ | 6.54▼ |
| MA20 | 3.49▲ | 3.68▼ | 3.88▼ | 5.05▼ | 7.79▼ |
| MA50 | 4.16▼ | 4.55▼ | 4.91▼ | 6.72▼ | 15.40▼ |
| MA100 | 4.54▼ | 5.50▼ | 6.11▼ | 8.17▼ | 40.08▼ |
| MA200 | 5.44▼ | 6.98▼ | 7.07▼ | 12.25▼ | 79.65▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.052▲ | 0.057▲ | 0.052▲ | -0.116▼ | 0.390▲ |
| RSI | 41.302▼ | 37.170▼ | 35.527▼ | 28.841▼ | 27.544▼ |
| STOCH | 56.838 | 82.256▲ | 67.641 | 10.558▼ | 9.467▼ |
| WILL %R | -25.641 | -13.514▲ | -56.164 | -86.445▼ | -93.639▼ |
| CCI | 11.192 | 51.683 | -6.981 | -79.296 | -161.092▼ |
|
Friday, May 16, 2025 12:22 PM
Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend" or the "Company"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment ...
|
|
Wednesday, May 14, 2025 06:31 AM
In this article, we are going to take a look at where Alzamend Neuro, Inc. (NASDAQ:ALZN) stands against other cheapest stocks insiders are buying in March. After solid gains Monday, the broader ...
|
|
Tuesday, May 13, 2025 05:00 AM
Topline data expected by year endHead-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/05/25 | 3.53 | 3.55 | 3.45 | 3.52 | 44,000 |
| 20/05/25 | 3.56 | 3.60 | 3.34 | 3.52 | 85,200 |
| 19/05/25 | 3.55 | 3.66 | 3.3106 | 3.60 | 155,440 |
| 16/05/25 | 3.28 | 3.48 | 3.056 | 3.40 | 123,100 |
| 15/05/25 | 3.83 | 3.83 | 3.16 | 3.29 | 173,200 |
| 14/05/25 | 4.01 | 4.069 | 3.83 | 3.85 | 238,700 |
| 13/05/25 | 6.115 | 6.12 | 3.938 | 4.18 | 5,775,300 |
| 12/05/25 | 5.58 | 5.789 | 5.03 | 5.15 | 159,381 |
| 09/05/25 | 4.86 | 5.94 | 4.68 | 5.922 | 349,100 |
| 08/05/25 | 5.04 | 5.0841 | 4.5909 | 4.86 | 410,533 |
|
|
||||
|
|
||||
|
|